MORPHOLOGICAL CHARACTERIZATION OF THE CELL-GROWTH INHIBITORY ACTIVITYOF ROOPEROL AND PHARMACOKINETIC ASPECTS OF HYPOXOSIDE AS AN ORAL PRODRUG FOR CANCER-THERAPY
Cf. Albrecht et al., MORPHOLOGICAL CHARACTERIZATION OF THE CELL-GROWTH INHIBITORY ACTIVITYOF ROOPEROL AND PHARMACOKINETIC ASPECTS OF HYPOXOSIDE AS AN ORAL PRODRUG FOR CANCER-THERAPY, South African medical journal, 85(9), 1995, pp. 853-860
It can be concluded from these findings that rooperol has promising pr
operties as an oral prodrug for cancer therapy in humans given its com
plete first-pass metabolism into non-toxic conjugates which may be act
ivated in tumours with high deconjugase activity. Rodent cancer models
are, however, not applicable since rooperol metabolites are completel
y sequestered in the bile.